Pinealon
Anecdote / communityAlso known as: Glu-Asp-Arg, EDR peptide
Community-reported ranges are anecdotal and not clinically validated. Evidence grade shown reflects the strength of available human data. Not a prescription. Legal status varies by country and changes over time; verify locally.
Overview
A short 'peptide bioregulator' (tripeptide) promoted for brain function, largely based on the work of a single research group. Independent human evidence is very limited.
Mechanism
Proposed to influence gene expression and protect neurons against oxidative stress; human significance is unclear.
Evidence
Very thin: limited, largely single-source research; treat cognitive claims sceptically.
Community-reported information
Community reports vary. Anecdotal and unvalidated; general information only.
General information only, not tailored to you and not a recommendation. Some regions withhold this entirely.
Half-life
Short.
Storage
Refrigerate solutions.
Commonly reported side effects
- Not well characterised in independent studies
Legal status by region
- USNot FDA-approved for human use.
Legal status changes over time; verify locally before relying on this.